GlassScriptPhysician profile
Robert Hugo Nunoo
NPI 1063662971
$9,071.06
in general payments reported to CMS, 2019-2025
20 companies · $352 in 2025
The $352 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,003 · 2020: $276 · 2021: $1,210 · 2022: $1,642 · 2023: $412 · 2024: $2,176 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,657 · Travel and Lodging: $1,283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,656.91 |
| Travel and Lodging | $1,283.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,230.84 | 2019-2024 | Enseal |
| Intuitive Surgical, INC. | $1,676.99 | 2019-2023 | Da Vinci Surgical System |
| Medtronic, INC. | $1,066.55 | 2022-2025 | Interstim, Infinity Occipitocervical Upper Thoracic System, Signia |
| Kerecis Limited | $1,058.51 | 2022 | |
| Stryker Corporation | $890.60 | 2021 | |
| Davol INC. | $411.66 | 2019-2024 | Phasix Mesh |
| Ethicon US, LLC | $406.46 | 2019-2024 | Echelon; Endopath |
| Axonics, INC. | $339.98 | 2021-2024 | Axonics |
| Tela Bio, INC. | $216.04 | 2020-2024 | Ovitex 2s |
| Boston Scientific Corporation | $155.88 | 2025 | Axonics |
| Myriad Genetic Laboratories, INC. | $142.71 | 2022-2024 | Myrisk |
| Viiv Healthcare Company | $121.83 | 2023 | Dovato |
| Merck Sharp & Dohme LLC | $93.84 | 2019 | |
| Conmed Corporation | $70.00 | 2019 | |
| Braintree Laboratories, INC. | $65.26 | 2020-2024 | Suflave, Sutab |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $52.61 | 2019-2020 | |
| Azurity Pharmaceuticals, INC. | $27.33 | 2025 | Suflave |
| Zimmer Biomet Holdings, INC. | $17.09 | 2025 | Ribfix Blu Advantage |
| Integra Lifesciences Corporation | $13.77 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Novo Nordisk INC | $13.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Nunoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.